Cardiovascular risk markers in hemodialysis patients

被引:7
作者
Urso, S [1 ]
Garozzo, M [1 ]
Milone, F [1 ]
Battaglia, G [1 ]
机构
[1] Osped S Matra & S Venera, Unita Operat Nefrol & Dialisi, Acireale, CT, Italy
关键词
homocysteine; troponin I; CK-MB mass; ESRD; HDF on-line; hemodialysis;
D O I
10.1177/039139880402701212
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cardiovascular events are the main cause of death in hemodialysis patients. Nevertheless, acute myocardial intarction may be misdiagnosed in Uremic patients, because typical markers have a high rate of false positivity. A recent two-year prospective study showed that predialytic high serum concentrations of troponin T and CK-MB mass were associated with high mortality, cardiac mortality, myocardial infarction and unstable angina (MACEs). We studied 16 uremic patients (13 M; 3 W) on standard HD and 6 patients (4 M; 2 W) on on-line HDF, who had been taking folic acid for at least three months. Patients who suffered from acute or chronic cardiac ischemic disease were excluded. Anthropometric parameters, pre and post-dialytic pH, HCO3 and electrolytes did not differ between the two groups. Kt/V and URR % were lower in conventional HD vs on-line HDF (p<0.04; p<0.04). ORR % was strongly elevated in on-line HDF compared with HD (p<0.005). In conventional HD, ORR % was directly correlated with Kt/V and URR % (r = 0.49, p<0.04; r = 0.48, p<0.04, respectively). Even in on-line HDF ORR % was directly correlated with Kt/V and URR % (r = 0.79, p<0.04; r = 0. 76, p<0.05, respectively). Troponin I and CK-MB mass were not significantly different in pre vs post-dialysis, both in standard HD and on-line HDF Nevertheless, in standard HD postdialytic troponin I correlated with serum sodium concentration (r = 0.93, p < 0.000), potassium (r = 0,67, p < 0.004) and serum chlorine (r = 0.92, p < 0.92, p < 0.000). CK-MB mass showed a correlation with serum chlorine (r = 0.49, p < 0.05). Postdialytic CK-MB mass correlated with serum potassium in on-line HDF (r = 0.83, p < 0.03). Our data suggest that hemodialytic treatments, both standard HD and on-line HDF, do not modify serum troponin I and CK-MB mass. Consequently, we can use these parameters for the diagnostic approach in acute or chronic ischemic heart disease in hemodialysis patients.
引用
收藏
页码:1083 / 1090
页数:8
相关论文
共 39 条
  • [1] Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease
    Apple, FS
    Murakami, MM
    Pearce, LA
    Herzog, CA
    [J]. CIRCULATION, 2002, 106 (23) : 2941 - 2945
  • [2] Influence of haemodialysis on plasma total homocysteine concentration
    Arnadottir, M
    Berg, AL
    Hegbrant, J
    Hultberg, B
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) : 142 - 146
  • [3] Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
    Bostom, AG
    Lathrop, L
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (01) : 10 - 20
  • [4] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
  • [5] Brattström L, 2000, AM J CLIN NUTR, V72, P315
  • [6] The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass
    Brulez, HFH
    van Guldener, C
    Donker, AJM
    ter Wee, PM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) : 154 - 159
  • [7] Measurement of cardiac troponins
    Collinson, PO
    Boa, FG
    Gaze, DC
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2001, 38 : 423 - 449
  • [8] Current markers of myocardial ischemia and their validity in end-stage renal disease
    George, SK
    Singh, AK
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (06) : 719 - 722
  • [9] Implications of troponin testing in clinical medicine
    Goldmann, BU
    Christenson, RH
    Hamm, CW
    Meinertz, T
    Ohman, EM
    [J]. CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (02): : 75 - 84
  • [10] Plasma homocysteine as a risk factor for vascular disease - The European concerted action project
    Graham, IM
    Daly, LE
    Refsum, HM
    Robinson, K
    Brattstrom, LE
    Ueland, PM
    PalmaReis, RJ
    Boers, GHJ
    Sheahan, RG
    Israelsson, B
    Uiterwaal, CS
    Meleady, R
    McMaster, D
    Verhoef, P
    Witteman, J
    Rubba, P
    Bellet, H
    Wautrecht, JC
    deValk, HW
    Luis, ACS
    ParrotRoulaud, FM
    Tan, KS
    Higgins, I
    Garcon, D
    Medrano, MJ
    Candito, M
    Evans, AE
    Andria, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22): : 1775 - 1781